» Articles » PMID: 37985868

The Immunoregulatory Roles of Non-haematopoietic Cells in the Kidney

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2023 Nov 21
PMID 37985868
Authors
Affiliations
Soon will be listed here.
Abstract

The deposition of immune complexes, activation of complement and infiltration of the kidney by cells of the adaptive and innate immune systems have long been considered responsible for the induction of kidney damage in autoimmune, alloimmune and other inflammatory kidney diseases. However, emerging findings have highlighted the contribution of resident immune cells and of immune molecules expressed by kidney-resident parenchymal cells to disease processes. Several types of kidney parenchymal cells seem to express a variety of immune molecules with a distinct topographic distribution, which may reflect the exposure of these cells to different pathogenic threats or microenvironments. A growing body of literature suggests that these cells can stimulate the infiltration of immune cells that provide protection against infections or contribute to inflammation - a process that is also regulated by draining kidney lymph nodes. Moreover, components of the immune system, such as autoantibodies, cytokines and immune cells, can influence the metabolic profile of kidney parenchymal cells in the kidney, highlighting the importance of crosstalk in pathogenic processes. The development of targeted nanomedicine approaches that modulate the immune response or control inflammation and damage directly within the kidney has the potential to eliminate the need for systemically acting drugs.

Citing Articles

Kidney immunology from pathophysiology to clinical translation.

Kurts C, von Vietinghoff S, Krebs C, Panzer U Nat Rev Immunol. 2025; .

PMID: 39885266 DOI: 10.1038/s41577-025-01131-y.


T cell metabolism in kidney immune homeostasis.

Liu Z, Dai B, Bao J, Pan Y Front Immunol. 2024; 15:1498808.

PMID: 39737193 PMC: 11684269. DOI: 10.3389/fimmu.2024.1498808.


Amplification of autoimmune organ damage by NKp46-activated ILC1s.

Biniaris-Georgallis S, Aschman T, Stergioula K, Schreiber F, Jafari V, Taranko A Nature. 2024; 634(8035):952-960.

PMID: 39137897 DOI: 10.1038/s41586-024-07907-x.


The immunology of systemic lupus erythematosus.

Tsokos G Nat Immunol. 2024; 25(8):1332-1343.

PMID: 39009839 DOI: 10.1038/s41590-024-01898-7.


[Update on lupus nephritis].

Schneider M, Schwarting A, Chehab G Z Rheumatol. 2024; 83(6):447-454.

PMID: 38935117 DOI: 10.1007/s00393-024-01534-7.


References
1.
Dai H, He F, Tsokos G, Kyttaris V . IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus. J Immunol. 2017; 199(3):903-910. PMC: 5526729. DOI: 10.4049/jimmunol.1700418. View

2.
Schwarting A, Relle M, Meineck M, Fohr B, Triantafyllias K, Weinmann A . Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men. Lupus. 2017; 27(2):243-256. DOI: 10.1177/0961203317717083. View

3.
Vlahakos D, Foster M, Adams S, Katz M, Ucci A, Barrett K . Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992; 41(6):1690-700. DOI: 10.1038/ki.1992.242. View

4.
Kanapathippillai P, Hedberg A, Fenton C, Fenton K . Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis. Cytokine. 2013; 62(2):244-52. DOI: 10.1016/j.cyto.2013.03.016. View

5.
Urbonaviciute V, Furnrohr B, Meister S, Munoz L, Heyder P, De Marchis F . Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med. 2008; 205(13):3007-18. PMC: 2605236. DOI: 10.1084/jem.20081165. View